InnoCan Pharma Corporation (CSE:INNO)

InnoCan Pharma Revenue

InnoCan Pharma had revenue of $7.01M USD in the quarter ending June 30, 2025, a decrease of -18.95%. This brings the company's revenue in the last twelve months to $28.83M, up 18.20% year-over-year. In the year 2024, InnoCan Pharma had annual revenue of $29.44M with 115.55% growth.

• Revenue (ttm): $28.83M
• Revenue Growth: +18.20%
• P/S Ratio: 2.36
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 92.91M CAD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	29.44M	15.78M	115.55%
Dec 31, 2023	13.66M	11.10M	433.69%
Dec 31, 2022	2.56M	2.36M	1,205.61%
Dec 31, 2021	196.00K	188.00K	2,350.00%
Dec 31, 2020	8.00K	-	-